Braveheart Bio to participate in Cantor Global Healthcare Conference
Braveheart Bio, Inc. announced it will participate in the Cantor Global Healthcare Conference.
SAN FRANCISCO, Sept.
01, 2026 (GLOBE NEWSWIRE) -- Braveheart Bio, Inc.
NASDAQ:BRVE, a clinical-stage biopharmaceutical company developing next-generation therapeutics for hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases, today announced that it will participate in the Can…